Liquid Biopsy Market Share Report 2022-2027

1
Global Liquid Biopsy Market Research and
Forecast Report 2022-2027




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Liquid Biopsy Market Research
Report According to the latest report by IMARC
Group, titled Liquid Biopsy Market Global
Industry Trends, Share, Size, Growth, Opportunity
and Forecast 2022-2027, the global liquid biopsy
market reached a strong growth in 2021.  Liquid
biopsy is the non-invasive sampling and analysis
of liquid state biological tissue, enabling
doctors to obtain information about diseases like
cancer and tumors. This technique can reflect the
changes in gene expression profile and provide a
robust base for individualized therapy. It is
used for monitoring and diagnosing diseases
through advanced procedures like human genome
sequencing. Liquid biopsy is a fast, convenient
and reproducible sampling method that facilitates
the early screening of cancer, monitors
progression, accesses therapeutic response and
clinical prognosis, and detects recurrent and
refractory tumors. Request Free Sample Report
https//www.imarcgroup.com/liquid-biopsy-market/re
questsample
4
Report Description and Highlights
Report Description
Global Liquid Biopsy Market Trends Liquid
biopsy reduces the apprehension of patients
regarding pain and provides a safe and effective
method of diagnosis. As a result, there has been
increasing demand for a non-invasive alternative,
such as liquid biopsy, over tissue biopsy that
involves the painful extraction of diseased
tissue, which is fueling the market growth. In
addition, the rising prevalence of cancer due to
environmental factors, tobacco consumption,
Hepatitis B and C, and lifestyle changes is also
escalating the demand for liquid biopsy. Besides
this, liquid biopsy is also widely adopted as
this technique detects epidermal growth factor
receptor (EGFR) gene mutation among patients with
non-small cell lung cancer (NSCLC). Furthermore,
technological advancements and extensive
investments in research and development (RD)
activities to encourage the introduction of
advanced cancer solutions are anticipated to
positively influence the market growth in the
upcoming years. Looking forward, the market
value is projected to reach a strong growth
during the forecast period (2022-2027).

5
Report Description and Highlights
Report Description

• Market Summary
• Breakup by Product and Service
• Kits and Reagents
• Platforms and Instruments
• Services
• Breakup by Circulating Biomarker
• Circulating Tumor Cells
• Extracellular Vesicles
• Circulating Tumor DNA
• Others

6
Report Description and Highlights
Report Description

• Breakup by Cancer Type
• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Liver Cancer
• Others
• Breakup by End User
• Hospitals and Laboratories
• Academic and Research Centers
• Others

7
Report Description and Highlights
Report Description

• Breakup by Region
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia

8
Report Description and Highlights
Report Description

• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• Note We are updating our reports, If you want
  latest primary and secondary data (2022-2027)
  with Cost Module, Business Strategy, Distribution
  Channel, etc. Click request free sample report.

9
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• ANGLE plc
• Biocept Inc.
• Bio-Rad Laboratories Inc
• Epigenomics AG
• Exact Sciences Corporation
• F. Hoffmann-La Roche AG
• Guardant Health Inc.
• Illumina Inc.
• MDxHealth SA
• Menarini Silicon Biosystems
• QIAGEN N.V.
• Thermo Fisher Scientific Inc
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/liquid-biopsy-market

10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
13

Contact Us